CPMD vs ABBV: Which Stock is Better?

Side-by-side comparison of Cannapharmarx, Inc. and Abbvie Inc in 2026

Comparison Updated:

CPMD

Cannapharmarx, Inc.

$0.00

ABBV

Abbvie Inc

$214.04

Key Metrics Comparison

MetricCPMDABBVWinner
Market Cap$3.51M$378.29BABBV
P/E RatioN/A160.93ABBV
EPS (TTM)$N/A$1.33ABBV
Revenue Growth1.1%0.1%CPMD
Gross Margin-192.1%71.5%ABBV

Analyze CPMD

Full quant analysis

Analyze ABBV

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CPMD or ABBV a better investment?

Comparing CPMD and ABBV: Cannapharmarx, Inc. has a market cap of $3.51M while Abbvie Inc has $378.29B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CPMD and ABBV?

CPMD (Cannapharmarx, Inc.) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CPMD or ABBV?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CPMD or ABBV?

CPMD has higher revenue growth at 1.1% vs 0.1% for ABBV.

Which company is more profitable: CPMD or ABBV?

Abbvie Inc (ABBV) has higher gross margins at 71.5% compared to -192.1% for CPMD.

Which is the larger company: CPMD or ABBV?

Abbvie Inc (ABBV) is larger with a market cap of $378.29B compared to $3.51M for CPMD.

Should I buy CPMD or ABBV in 2026?

Both CPMD and ABBV have investment merit. CPMD trades at $0.00 while ABBV trades at $214.04. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CPMD and ABBV stock?

Key differences: Market Cap ($3.51M vs $378.29B), P/E Ratio (N/A vs 160.9x), Revenue Growth (1.1% vs 0.1%), Gross Margin (-192.1% vs 71.5%).

Popular Stock Comparisons